June 20, 2017 | Marc Williams, Director of Geisinger Health System's Genomic Medicine Institute, is featured on this podcast from Cambridge Health Tech Institute for the Next Generation Diagnostic Summit, which runs August 15th to the 18th in Washington, DC. Topics include implementation of NGS in routine car, challenges to overcome, and exciting applications of NGS. Here is a sample of the discussion that takes place. Podcast
CHI: What are some new applications of next generation sequencing that you are most excited about?
Marc Williams: … By using the genome sequence information to identify individual that carry a pathogenic variant in one of the genes that are associated with one of these conditions, we're identifying a large number of people that had not been previously identified and are intervening in their care in a way that at least based on our preliminary, primarily anecdotal information, seems to be improving outcomes. This is really exciting and I think it's reinforcing the importance of the project that we're doing and reinforcing also how critical it is that we capture the outcomes from this return of results in an efficient way. But I think if our preliminary results continue to hold true, there really is the opportunity that this approach will revolutionize how we think about identification of individuals at risk for genetic disorders.